Live Updates:

On | Off

  • PDL BIOPHARMA INC Income Statement

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2009 FY2008 FY2007 FY2006 FY2005
    Net Sales/Revenues 318.18 M 294.27 M 258.92 M 249.07 M 279.65 M
    Cost of Goods Sold (Excluding Depreciation) 0.00 0.00 0.00 0.00 7.57 M
    Depreciation, Depletion and Amortization 991,000.00 22.49 M 64.49 M 75.67 M 52.68 M
    Gross Income 317.19 M 271.78 M 194.43 M 173.40 M 219.40 M
    Selling, General & Admin Expenses 5.82 M 28.85 M 196.05 M 186.96 M 254.42 M
    Other Operating Expense 14.26 M 0.00 0.00 0.00 0.00
    Operating Expenses - Total 2.21 M 10.07 M 29.31 M 41.39 M 33.23 M
    Operating Income 297.12 M 242.93 M -1.62 M -13.56 M -35.03 M
    Extraordinary Credit - Pretax 1.52 M 0.00 0.00 0.00 0.00
    Extraordinary Charge - Pretax 0.00 200,000.00 24.08 M 900,000.00 130.12 M
    Non-operating Interest Income 1.00 M 14.90 M 20.26 M 17.70 M 9.92 M
    Reserves Inc (Dec) 0.00 0.00 0.00 0.00 0.00
    Pretax Equity in Earnings
    Other Income/Expenses - Net 0.00 0.00 0.00 0.00 -300,000.00
    Earnings Before Interest & Taxes (EBIT) 299.64 M 257.63 M -5.44 M 3.24 M -155.53 M
    Interest Expenses On Debt 19.36 M 14.22 M 16.81 M 14.77 M 14.08 M
    Interest Capitalized 0.00 0.00 3.10 M 1.70 M 3.90 M
    Pretax Income 280.28 M 243.41 M -19.14 M -9.82 M -165.71 M
    Income Taxes 90.62 M 5.01 M 247,000.00 941,000.00 868,000.00
    Current Domestic Income Tax 86.83 M 27.19 M 124,000.00 860,000.00 821,000.00
    Current Foreign Income Tax 3.80 M -22.18 M 123,000.00 81,000.00 47,000.00
    Deferred Domestic Income Tax 0.00 0.00 0.00 0.00 0.00
    Deferred Foreign Income Tax 0.00 0.00 0.00 0.00 0.00
    Income Tax Credits
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Equity in Earnings 0.00 0.00 0.00 0.00 0.00
    After Tax Income Expense 0.00 0.00 0.00 0.00 0.00
    Discontinued Operations 0.00 -170.01 M -1.67 M -119.25 M 0.00
    Net Income Before Extra Items/Preferred Div 189.66 M 68.39 M -21.06 M -130.02 M -166.58 M
    Extra Items & Gain (Loss) Sale of Assets 0.00 0.00 0.00 0.00 0.00
    Net Income Before Preferred Dividends 189.66 M 68.39 M -21.06 M -130.02 M -166.58 M
    Preferred Dividend Requirements 0.00 0.00 0.00 0.00 0.00
    Net Income Available to Common 196.74 M 68.39 M -21.06 M -130.02 M -166.58 M